Pyramid Biosciences is a provider of biotechnological services.
Pyramid Biosciences has raised $33.5M in total funding. The most recent round was Series B. The last funding was announced in October 2021.
Pyramid Biosciences's investors include Adage Capital Management, Prospect Hill Growth Partners, Alpine Meridian, Oracle Investment Management Inc., Boston Harbor Angels.
Pyramid Biosciences is headquartered in Needham, United States.
Pyramid Biosciences is a provider of biotechnological services.
Pyramid Biosciences is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pyramid Biosciences — Funding & Investors." VCBacked, October 15, 2021, https://www.vcbacked.co/company/pyramid-biosciences. Accessed August 15, 2026.
VCBacked. (2021). Pyramid Biosciences — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/pyramid-biosciences
{{cite web |title=Pyramid Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/pyramid-biosciences |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated